Joep joined Gilde Healthcare in 2021. He focuses on investing in late-stage opportunities including publicly traded companies that deliver better care at lower cost. He is actively engaged in multi-stakeholder interaction and is responsible for coordinating Gilde’s Impact Council.

Before joining Gilde, he served as CFO and Chief of Portfolio Strategy at Boston-based biotech company PureTech Health (PRTC), developing highly differentiated medicines for devastating diseases. Prior to PureTech, Joep worked as Partner and Portfolio Manager at LSP for 12 years and gained experience in life sciences investment banking in his role as Director of Corporate Finance and Capital Markets at Fortis Bank.

Joep holds a PhD in Molecular Biology from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and a Master’s degree in Biochemistry from the University of Nijmegen, the Netherlands.